The antibody recognises CD2 antigen found on most thymocytes, T lymphocytes and splenic tissue macrophages. The OX-55 antigen has same distribution as OX-34 and OX-54 antigens but does not compete.
| Institute |
|---|
| Medical Research Council; University of Oxford |
| SKU: | 156592 |
|---|---|
| Product description: | The antibody recognises CD2 antigen found on most thymocytes, T lymphocytes and splenic tissue macrophages. The OX-55 antigen has same distribution as OX-34 and OX-54 antigens but does not compete. |
| Conjugation: | Unconjugated |
| Immunogen: | Purified rat CD2 |
| Myeloma used: | NS0/1 |
| Cat. #: | 156592 |
|---|---|
| Unit size: | 100 ug |
| Application: | FACS ; IHC |
| Target: | CD2 |
| Reactivity: | Rat |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | The antibody recognises CD2 antigen found on most thymocytes, T lymphocytes and splenic tissue macrophages. The OX-55 antigen has same distribution as OX-34 and OX-54 antigens but does not compete. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Jefferies et al. 1985. J Exp Med. 162(1):117-27. PMID: 3159821. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.